Baba A, Cook D, McGarity T, Bero L. Legislating "Sound Science": The role of the tobacco industry. American Journal of Public Health. 2005;95(Suppl 1):s20-27.
Bero L. Tobacco industry manipulation of research. Public Health Reports. 2005;120:200-208.
Bero L, Glantz S, Hong M-K. The limits of competing interest disclosures. Tobacco Control. 2005;14:118-126.
Bialous S, Yach D. Whose standard is it anyway? How the tobacco industry determines the international organization for standardization (ISO) standards for tobacco and tobacco products. Tobacco Control. 2001;10:96-104.
Bitton A, Neuman M, Barnoya J, Glantz S. The p53 tumor suppressor gene and the tobacco industry: Research, debate, and conflict of interest. Lancet. 2005;365:531-540.
Callahan P, Manier J, Alexander D. Where there's smoke, there might be food research, too. Documents indicate Kraft, Philip Morris shared expertise on how the brain processes tastes, smells. Chicago Tribune. 2006 29 January.
Carpenter C, Wayne G, Connolly G. The role of sensory perception in the development and targeting of tobacco products. Addiction. 2007;102(1):136-47.
Cataldo JK, Bero LA, Malone RE. “A delicate diplomatic situation”: tobacco industry efforts to gain control of the Framingham Study. J.Clin.Epidemiol. 2010 8;63(8):841-853. http://dx.doi.org/10.1016/j.jclinepi.2010.01.021.
Cataldo JK, Prochaska JJ, Glantz SA. Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation. J Alzheimers Dis. 2010 Oct 8;19(2):465-480. http://dx.doi.org/10.3233/JAD-2009-1240.
Chapman S. "It is possible he is a kind of nut": How the tobacco industry quietly promoted Dr William Whitby. Tobacco Control. 2003;12(Suppl 3):4-6.
Chapman S. "We are anxious to remain anonymous": The use of third party scientific and medical consultants by the Australian tobacco industry, 1969 to 1979. Tobacco Control. 2003;12(Suppl 3):iii31-37.
Chapman S. Research from tobacco industry affiliated authors: Need for particular vigilance. Tobacco Control. 2005;14:217-219.
Chapman S, Liberman J. Ensuring smokers are adequately informed: Reflections on consumer rights, manufacturer responsibilities, and policy implications. Tobacco Control. 2005;14(Suppl 2):ii8-13.
Chapman S, Shatenstein S. The ethics of the cash register: Taking tobacco research dollars. Tobacco Control. 2001;10:1-2.
Cook D, Tong E, Glantz S, Bero L. The power of paperwork: How Philip Morris neutralized the medical code for secondhand smoke. The use of politics to influence science. Health Affairs. 2005;24:993-1004.
Daube M. Why Kenneth Clarke is unfit to be Tory leader. BMJ. 2005;331:912.
Fields N, Chapman S. Chasing Ernst l Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. Journal of Epidemiology and Community Health. 2003;57:571-78.
Gan Q, Glantz SA. Relationship between the Chinese tobacco industry and academic institutions in China. Tobacco Control 2010;ePub before print. http://tobaccocontrol.bmj.com/content/early/2010/10/15/tc.2010.036079.abstract.
Giles J. Big brains payrolled by big tobacco. New Scientist. 2008 20 February 2008.
Givelber D, Strickler L. Junking good science: Undoing Daubert v. Merrill Dow through cross- examination and argument. American Journal of Public Health. 2006;9(1):33-37. doi:10.2105/AJPH.2005.063917
Goldstein A. Institutional addiction to tobacco. Tobacco Control. 1999;8:70-74.
Grannis F. (correspondence.) Overestimation of lung cancer mortality in a computed tomography-screened population. Patz EF, Swensen SJ, Herndon JE II. (in reply.) Journal of Clinical Oncology. 2005;23:2439-2441.
Gruning D, Gilmore A, McKee M. Tobacco industry influence on science and scientists in Germany. American Journal of Public Health. 2006;96(1):20-32. doi:10.2105/AJPH.2004.061507
Gundle KR, Dingel MJ, Koenig BA. 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction. Addiction 2010;105(6):974-983. http://dx.doi.org/10.1111/j.1360-0443.2010.02940.x.
Gunja M, Wayne G, Landman A, Connolly G, McGuire A. The case for fire safe cigarettes made through industry documents. Tobacco Control. 2001;11:346-353.
Hammond D, Collishaw N, Callard C. Secret science: Tobacco industry research on smoking behaviour and cigarette toxicity. Lancet. 2006;367(9512):781-87.
Hardell L, Walker M, Walhjalt B, Friedman L, Richter E. Secret ties to industry and conflicting interests in cancer research. American Journal of Industrial Medicine. 2007;50(3):227-233. doi:10.1002/ajim.20357
Healy D. Are Selective Serotonin Reuptake Inhibitors a Risk Factor for Adolescent Suicide? Canadian Journal of Psychiatry 2009 02;54(2):69-71. http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=36850655&site=ehost-live.
Hiilamo H. Manufacturing lies: Tobacco industry research funding in Finland. Helsinki: ASH: Finland; 2004.
Hirschhorn N. Shameful science: Four decades of the German tobacco industry's hidden research on smoking and health. Tobacco Control. 2000;9:242-247.
Hirschhorn N, Bialous S, Shatenstein S. Philip Morris' new scientific initiative: An analysis. Tobacco Control. 2001;10:247-252.
Hirschhorn N, Bialous S, Shatenstein S. The Philip Morris external research program: Results from the first round of projects. Tobacco Control. 2006;15(3):267-69.
Hirshbein L. Scientific Research and Corporate Influence: Smoking, Mental Illness, and the Tobacco Industry. J.Hist.Med.Allied Sci. 2011 May 19. http://dx.doi.org/10.1093/jhmas/jrr019.
Hong M, Bero L. Tobacco industry sponsorship of a book and conflict of interest. Addiction. 2006;101(8):1202-11.
Kreslake J, Wayne G, Connolly G. The menthol smoker: Tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine & Tobacco Research. 2008 Apr;10(4):705-15. doi:10.1080/14622200801979134
Kummerfeldt CE, Barnoya J, Bero LA. Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tobacco Control. 2009 Feb 11;[Epub ahead of Print]. doi: http://dx.doi.org/10.1136/tc.2008.026989
Jackler RK, Samji HA. The price paid: Manipulation of otolaryngologists by the tobacco industry to obfuscate the emerging truth that smoking causes cancer. Laryngoscope 2012;122(1):75-87. http://dx.doi.org/10.1002/lary.22358
Kyriss T, Schneider NK. The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines. Tobacco Control 2012 September 02. http://dx.doi.org/10.1136/tobaccocontrol-2012-050696.
Leistikow B, Martin D, Jacobs J, Rocke D. Smoking as a risk factor for injury death: A meta-analysis of cohort studies. Preventive Medicine. 1998;27:871-878.
Mackenzie R, Collin J. "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok. PLoS Med. 2008 Dec 23;5(12):e238. doi:10.1371/journal.pmed.0050238
Mashey J. Fake science, fakexperts, funny finances, free of tax. Feb 14 2012. Available at: http://www.desmogblog.com/fake-science-fakexperts-funny-finances-free-tax.
Mashey J. See No Evil, Speak Little Truth, Break Rules, Blame Others. Aug 19 2012. http://www.desmogblog.com/sites/beta.desmogblog.com/files/see.no_.evil_.speak_.little.truth_.pdf.
Megerdichian C, Rees V, Ferris Wayne G, Connolly G. Internal tobacco industry research on olfactory and trigeminal nerve response to nicotine and other smoke components. Nicotine & Tobacco Research. 2007 Nov;9(11):1119-29.
Michaels D, Monforton C. Manufacturing uncertainty: Contested science and the protection of the public’s health and environment. American Journal of Public Health. 2005;95(Suppl 1):s39-48.
Monbiot G. Exposed: The secret corporate funding behind health research. The Guardian (Education Guardian). 2006 7 February 2006.
Neuman M, Bitton A, Glantz S. Tobacco industry influence on the definition of tobacco related disorders by the American Psychiatric Association. Tobacco Control. 2005;14:328-337.
Ong E, Glantz S. Tobacco industry efforts subverting the International Agency for Research on Cancer's second-hand smoke study. Lancet. 2000;355:1253-1259.
Ong E, Glantz S. Constructing "Sound science" And "Good epidemiology": Tobacco, lawyers, and public relations firms. American Journal of Public Health. 2001;91:1749-1757.
Oreskes N, Conway EM. Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. New York: Bloomsbury Press; 2010.
Panzano VC, Wayne GF, Pickworth WB, Connolly GN. Human electroencephalography and the tobacco industry: a review of internal documents. Tobacco Control 2010 Apr;19(2):153-159. http://dx.doi.org/10.1136/tc.2009.032805.
Parascandola M. Hazardous effects of tobacco industry funding. Journal of Epidemiology and Community Health. 2003;57:548-549.
Parascandola M. Science, industry, and tobacco harm reduction: A case study of tobacco industry scientists’ involvement in the National Cancer Institute’s smoking and health program, 1964–1980. Public Health Reports. 2005;120:338-349.
Parascandola M. Lessons from the history of tobacco harm reduction: The National Cancer Institute’s smoking and health program and the "less hazardous cigarette." Nicotine & Tobacco Research. 2005;7:779-789.
Petticrew MP, Lee K. The "Father of Stress" Meets "Big Tobacco": Hans Selye and the Tobacco Industry. American Journal of Public Health 2010 May 13. http://dx.doi.org/10.2105/AJPH.2009.177634.
Petticrew M, Lee K, McKee M. Type A Behaviour Pattern and Coronary Heart Disease: Philip Morris’ “Crown Jewel”. Journal of Epidemiology and Community Health 2012 September 01;66(Suppl 1):A30-A30. http://dx.doi.org/10.1136/jech-2012-201753.077.
Pollay R. Propaganda, puffing and the public interest: The scientific smoke screen for cigarettes. Public Relations Review. 1990;16:27-42.
Rasmussen N. Maurice Seevers, the stimulants and the political economy of addiction in American biomedicine. BioSocieties 2010;5:105-123. http://www.palgrave-journals.com/biosoc/journal/v5/n1/full/biosoc20097a.html.
Rees VW, Kreslake JM, O'Connor RJ, Cummings KM, Parascandola M, Hatsukami D, et al. Methods used in internal industry clinical trials to assess tobacco risk reduction. Cancer Epidemiology Biomarkers & Prevention. December 2009;18(12):3196-3208. http://cebp.aacrjournals.org/content/18/12/3196.abstract
Rees VW, Kreslake JM, Cummings KM, O'Connor RJ, Hatsukami DK, Parascandola M, et al. Assessing consumer responses to potential reduced-exposure tobacco products: A review of tobacco industry and independent research methods. Cancer Epidemiology Biomarkers & Prevention. December 2009;18(12):3225-3240. http://cebp.aacrjournals.org/content/18/12/3225.abstract
Salgado MV, Glantz SA. Direct disease-inducing effects of menthol through the eyes of tobacco companies. Tobacco Control 2011 May 01;20(Suppl 2):ii44-ii48. http://tobaccocontrol.bmj.com/content/20/Suppl_2/ii44.abstract.
Samet J, Burke T. Turning science into junk; the tobacco industry and passive smoking. American Journal of Public Health. 2001;91:1742-44.
Schick S, Glantz S. Old ways, new means: Tobacco industry funding of academic and private sector scientists since the master settlement agreement. Tobacco Control. 2007 Jun;16(3):157-64.
Smith EA, Novotny TE. Whose butt is it? tobacco industry research about smokers and cigarette butt waste. Tobacco Control 2011 May;20 Suppl 1:i2-9. http://dx.doi.org/10.1136/tc.2010.040105.
Thompson G, Signal L. Associations between universities and the tobacco industry: What institutional policies limit these associations? Social Policy Journal of New Zealand. 2005;26.
Thomson G, Signal L. Associations between universities and the tobacco industry: What institutional policies limit these associations? Social Policy Journal of New Zealand. 2005;26:186-204.
Thun M. More misleading science from the tobacco industry. BMJ. 2003;3:352-353.
Tong E, England L, Glantz S. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry. Pediatrics. 2005;115:356-366.
Tong E, Glantz S. ARTIST (Asian Regional Tobacco Industry Scientist Team ): Philip Morris’ attempt to exert a scientific and regulatory agenda on Asia. Tobacco Control. 2004;13(Suppl 2):ii118-124.
Tong E, Glantz S. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007 Oct;116(16):1845-54. doi:10.1161/CIRCULATIONAHA.107.715888
Tuffs A. German heart specialist received research grant from tobacco industry foundation. BMJ. 2008;337:a2085. doi:10.1136/bmj.a2085
Warner K. Tobacco industry scientific advisors: Serving society or selling cigarettes? American Journal of Public Health. 1991;81:839-842.
Wayne G, Connolly G, Henningfield J. Assessing internal tobacco industry knowledge of the neurobiology of tobacco dependence. Nicotine & Tobacco Research. 2004;6:927-940.
Wertz MS, Kyriss T, Paranjape S, Glantz SA,. The Toxic Effects of Cigarette Additives. Philip Morris' Project Mix Reconsidered: An Analysis of Documents Released through Litigation. PLoS Med 2011 12/20;8(12):e1001145.
White J, Bandura A, Bero LA. Moral disengagement in the corporate world. Accountability in Research. 2009;16(1):41 - 74. http://www.informaworld.com/10.1080/08989620802689847
White J, Bero L. SYMPOSIUM: ACADEMIC INTEGRITY: Corporate Manipulation of Research: Strategies Are Similar Across Five Industries. Stanford Law & Policy Review 2010;21(2). http://slpr.stanford.edu/previous.html; http://www.lexisnexis.com/.
White J, Parascandola M, Bero L. Tobacco industry research and protection of human subjects: A case study of RJ Reynolds. Nicotine & Tobacco Research. 2007 Nov;9(11):1213-25.
Yach D, Bialous S. Junking science to promote tobacco. American Journal of Public Health. 2001;91:1745-1748.
Yach D, Bialous S. Yach and Bialous respond [to James Stanley, “Ilsi and the tobacco industry” American Journal of Public Health 2002;92:891-892]. American Journal of Public Health. 2002;92:892-893.
Yano E. Japanese spousal smoking study revisited: How a tobacco industry funded paper reached erroneous conclusions. Tobacco Control. 2005;14:227-235.